Coherus BioSciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
17.75
|
|
Average Rating
|
3.88
|
|
# Strong Buys
|
2
|
|
# Buys
|
3
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.57
|
-0.96
|
-0.39
|
-68.42%
|
|
2022-06-30
|
-0.64
|
-0.47
|
0.17
|
26.56%
|
|
2022-03-31
|
-0.48
|
-1.00
|
-0.52
|
-108.33%
|
|
2021-12-31
|
-0.51
|
-0.46
|
0.05
|
9.80%
|
|
2021-09-30
|
-0.22
|
-0.34
|
-0.12
|
-54.55%
|
|
2021-06-30
|
-0.15
|
-0.36
|
-0.21
|
-140.00%
|
|
2021-03-31
|
0.07
|
0.01
|
-0.06
|
-85.71%
|
|
2020-12-31
|
0.23
|
0.12
|
-0.11
|
-47.83%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.43
|
|
2021-12-31
|
-1.15
|
|
2020-12-31
|
1.63
|
|
2019-12-31
|
1.22
|
|
2018-12-31
|
-3.21
|
|
2017-12-31
|
-4.55
|
|
2016-12-31
|
-3.43
|
|
2015-12-31
|
-5.99
|
|
2014-12-31
|
-3.26
|